CALL/MERCK & CO./160/0.1/17.01.25 | Real-time BOERSE MUENCHEN 08:25:13 2024-07-12 am EDT | ||
| 0.061 EUR | +1.67% |
|
| Current month | -17.81% | ||
| 1 month | -32.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.061 | +1.67% |
| 24-07-11 | 0.06 | +22.45% |
| 24-07-10 | 0.049 | -3.92% |
| 24-07-09 | 0.051 | 0.00% |
| 24-07-08 | 0.051 | +6.25% |
Real-time BOERSE MUENCHEN
Last update July 12, 2024 at 08:25 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GP7C46 |
| ISIN | DE000GP7C460 |
| Date issued | 2023-06-29 |
| Strike | 160 $ |
| Maturity | 2025-01-17 (189 Days) |
| Parity | 10 : 1 |
| Emission price | 0.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.195 € |
|---|---|
| Lowest since issue | 0.019 € |
| Spread | 0.02 € |
| Spread % | 24.39% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129
USD
Average target price
142.6
USD
Spread / Average Target
+10.54%
- Stock Market
- Warrants
- Warrant
